Words from a Leading Oncologist, Prof. David Gandara regarding FDA approval of Guardant360® CDx
Home » Words from a Leading Oncologist, Prof. David Gandara regarding FDA approval of Guardant360® CDx

GH AMEA on Social Media Words from a Leading Oncologist, Prof. David Gandara regarding FDA approval of Guardant360® CDx
Words from a Leading Oncologist, Prof. David Gandara regarding FDA approval of Guardant360® CDx
Words from a Leading Oncologist, Prof. David Gandara regarding FDA approval of Guardant360® CDx
GH AMEA

Hear what Prof. David Gandara, MD, a world-renowned oncologist, has to say about Guardant360® CDx becoming the first liquid biopsy to receive FDA Approval for comprehensive tumor mutation profiling across all solid cancers. This one-minute video clip is captured from a recently conducted webinar earlier this month.

Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at clientservices@guardantamea.com or contact us on WhatsApp: +65 8940 0360.

Guardant360®. Test. Take Action.

View full press release at this link: https://lnkd.in/gwAmpCD

Open chat
Message us
Words from a Leading Oncologist, Prof. David Gandara regarding FDA approval of Guardant360® CDx - Guardant Health AMEA

Words from a Leading Oncologist, Prof. David Gandara regarding FDA approval of Guardant360® CDx
Home » Words from a Leading Oncologist, Prof. David Gandara regarding FDA approval of Guardant360® CDx

GH AMEA on Social Media Words from a Leading Oncologist, Prof. David Gandara regarding FDA approval of Guardant360® CDx
Words from a Leading Oncologist, Prof. David Gandara regarding FDA approval of Guardant360® CDx
Words from a Leading Oncologist, Prof. David Gandara regarding FDA approval of Guardant360® CDx
GH AMEA

Hear what Prof. David Gandara, MD, a world-renowned oncologist, has to say about Guardant360® CDx becoming the first liquid biopsy to receive FDA Approval for comprehensive tumor mutation profiling across all solid cancers. This one-minute video clip is captured from a recently conducted webinar earlier this month.

Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at clientservices@guardantamea.com or contact us on WhatsApp: +65 8940 0360.

Guardant360®. Test. Take Action.

View full press release at this link: https://lnkd.in/gwAmpCD

Open chat
Message us